Abstract:Neuropathic pain (NP) is a prevalent disease, which badly impairs the life quality of patients. The underlying mechanism of NP is still not fully understood. It has been reported that spinal Annexin A10 (ANXA10) contributes to NP. This study aims at exploring the underlying mechanisms of spinal ANXA10 in regulating NP in rats. Spinal nerve ligation (SNL) was adopted to establish a NP model in rats. After SNL, paw withdrawal threshold and paw withdrawal latency were recorded to measure pain behaviors, RT-PCR was used to check the change of the expression of spinal ANXA10 mRNA, western blot analysis was used to detect the change of the protein level of ANXA10, nuclear factor kappa B (NF-κB), and maisrix metalloproteinase-9 (MMP-9) in the spinal cord. The levels of proinflammatory cytokines, including tumor necrosis factor-α (TNF-α), interleukine-1β (IL-1β), and interleukine-6 (IL-6), were explored by ELISA kits. The effects of both knockdown of spinal ANXA10 and inhibition of NF-κB on pain behaviors and the expression of MMP-9 and proinflammatory cytokines were investigated. Our present findings highlighted that SNL caused pain hypersensitivity and increased the expression of spinal ANXA10/pNF-κB, TNF-α, IL-1β, and IL-6 both in the early and late phase of NP in rats, while spinal MMP-9 was only slightly increased in the early phase of NP. Knockdown of ANXA10 at the spinal cord level suppressed the SNL-induced hyperalgesia and blocked the activation of NF-κB, TNF-α and IL-1β both in the early and late phase of NP. Spinal ANXA10 knockdown could prevent the upregulation of spinal MMP-9 in the early phase and inhibit IL-6 expression in the late phase of SNL-induced NP. In conclusion, spinal ANXA10/NF-κB/MMP-9 pathway, along with the activation of proinflammatory cytokines, was involved in the SNL-induced NP. MMP-9 may act as the downstream target of ANXA10/NF-κB pathway in the development rather than the maintenance of NP.

[Expression of voltage gated sodium channel Nav1.9 in experimental pulpal lesions in the rats].

Expression of voltage gated sodium channel Nav1. 7 in rat pulpitis

Expression of sodium channel subtypes Nav1 . 3 in experimental pulpitis in rats

Expression of sodium channel Nav1.7 in rat pulpitis

[Expression of Nav1.8 in Human Dental Pulp].

The Involvement of Spinal Annexin A10/NF-κB/MMP-9 Pathway in the Development of Neuropathic Pain in Rats

Inhibiting Nav1.7 channels in pulpitis: An in vivo study on neuronal hyperexcitability

Pulpitis pain relief by modulating sodium channels in trigeminal ganglia

Voltage‐gated Sodium Channel 1.7 Expression Decreases in Dorsal Root Ganglia in a Spinal Nerve Ligation Neuropathic Pain Model

Exploring the mechanism of Nav1.3 in the ION-CCI rat model based on the TLR4/TRAF6/NF-κB pathway

Changes In The Expression Of Voltage-Gated Sodium Channels Na(V)1.3, Na(V)1.7, Na(V)1.8, And Na(V)1.9 In Rat Trigeminal Ganglia Following Chronic Constriction Injury

Persistent (Nav1.9) sodium currents in human dorsal root ganglion neurons

Effect of Pulsed Radiofrequency Application to Dorsal Root Ganglias on Neuronal Nav1.8 Expression in a Rat Model of Inflammatory Pain

The expression of voltage-gated sodium channels in trigeminal nerve following chronic constriction injury in rats

Upregulation of Nav1.3 Channel Induced by Rrtnf in Cultured Adult Rat DRG Neurons Via P38 MAPK and JNK Pathways.

Role of TLR4/NF-κB Signaling Pathway in Development of Postoperative Chronic Pain in Rats: the Relationship with Expression of Nav 1. 7 in Dorsal Root Ganglion

Computational modeling to study the impact of changes in Nav1.8 sodium channel on neuropathic pain

TNF-α contributes to up-regulation of Nav1.3 and Nav1.8 in DRG neurons following motor fiber injury

Correlative Increasing Expressions of KIF5b and Nav1.7 in DRG Neurons of Rats under Neuropathic Pain Conditions

Effect of TNF-α on Expression of Nav1.3 Channels in Dorsal Root Ganglion

Activation of the P2X7 receptor in the dental pulp tissue contributes to the pain in rats with acute pulpitis